A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
Titel:
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia
Auteur:
Uy, Geoffrey L. Rettig, Michael P. Motabi, Ibraheem H. McFarland, Kyle Trinkaus, Kathryn M. Hladnik, Lindsay M. Kulkarni, Shashikant Abboud, Camille N. Cashen, Amanda F. Stockerl-Goldstein, Keith E. Vij, Ravi Westervelt, Peter DiPersio, John F.